CEBP  Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Park, J. Y.
Right arrow Articles by Jung, T. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Park, J. Y.
Right arrow Articles by Jung, T. H.
Cancer Epidemiology Biomarkers & Prevention Vol. 11, 23-27, January 2002
© 2002 American Association for Cancer Research

Polymorphism of the DNA Repair Gene XRCC1 and Risk of Primary Lung Cancer1

Jae Yong Park2, Su Yeon Lee, Hyo-Sung Jeon, Nack Chun Bae, Sang Chul Chae, Soyoung Joo, Chang Ho Kim, Jae-Ho Park, Sin Kam, In San Kim and Tae Hoon Jung

Department of Internal Medicine, Kyungpook National University Hospital, Samduk 2ga 50, Taegu, 700-412 [J. Y. P., N. C. B., S. C. C., C. H. K., T. H. J.]; Department of Internal Medicine, School of Medicine, Keimyung University, Dongsan Dong 194, Taegu, 700-712 [J-H. P.]; and Cancer Research Institute [J. Y. P., S. Y. L., S. J.], Departments of Biochemistry [H-S. J., I. S. K.] and Preventive Medicine [S. K.], School of Medicine, Kyungpook National University, Dong In 2Ga 101, Taegu, 700-422, Korea

DNA repair plays a critical role in protecting the genome of the cell from insults of cancer-causing agents, such as those found in tobacco smoke. Reduced DNA repair capacity, therefore, can increase the susceptibility to smoking-related cancers. Recently, three coding polymorphisms in X-ray cross-complementing group 1 (XRCC1) DNA repair gene have been identified, and it is possible that these polymorphisms may affect DNA repair capacity and thus modulate cancer susceptibility. We investigated the relationship between the codon 399 polymorphism in XRCC1 gene and lung cancer risk in male smokers. The study population consisted of 192 lung cancer patients and 135 healthy controls. The distribution of XRCC1 genotypes was not significantly different between cases and controls. When the cases were categorized by histological type, however, the presence of at least one Gln allele was associated with a significant increased risk for squamous cell carcinoma [crude odds ratio (OR) = 1.77, 95% confidence interval (CI) = 1.06–2.93 and adjusted OR = 1.66, 95% CI = 0.99–2.79]. The risk for the disease increased as the number of Gln alleles increased (Arg/Gln genotype: adjusted OR = 1.45, 95% CI = 0.84–2.5; Gln/Gln genotype: adjusted OR = 3.26, 95% CI = 1.17–9.15). When the subjects dichotomized by cigarette consumption into two pack-year groups (<=40 pack-years, >40 pack-years), the Gln allele was associated with an increased risk for squamous cell carcinoma only in the group of individuals having <=40 pack-years of smoking (Arg/Gln genotype: adjusted OR = 1.48, 95% CI = 0.78–2.8; Gln/Gln genotype: adjusted OR = 5.75, 95% CI = 1.46–22.69). These results suggest that XRCC1 codon 399 polymorphism may be an important genetic determinant of squamous cell carcinoma of the lung in persons with lower degrees of cigarette use.




This article has been cited by other articles:


Home page
Jpn J Clin OncolHome page
K. Arizono, Y. Osada, and Y. Kuroda
DNA Repair Gene hOGG1 Codon 326 and XRCC1 Codon 399 Polymorphisms and Bladder Cancer Risk in a Japanese Population
Jpn. J. Clin. Oncol., March 1, 2008; 38(3): 186 - 191.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
M. C. Shin, S. J. Lee, J. E. Choi, S. I. Cha, C. H. Kim, W. K. Lee, S. Kam, Y. M. Kang, T. H. Jung, and J. Y. Park
Glu346Lys Polymorphism in the Methyl-CpG Binding Domain 4 Gene and the Risk of Primary Lung Cancer
Jpn. J. Clin. Oncol., August 1, 2006; 36(8): 483 - 488.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Y. Jung, J. E. Choi, J. M. Park, M. H. Chae, H.-G. Kang, K. M. Kim, S. J. Lee, W. K. Lee, S. Kam, S. I. Cha, et al.
Polymorphisms in the hMSH2 Gene and the Risk of Primary Lung Cancer.
Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 762 - 768.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
C.-C. Chen, S.-Y. Yang, C.-J. Liu, C.-L. Lin, Y.-F. Liaw, S.-M. Lin, S.-D. Lee, P.-J. Chen, C.-J. Chen, and M.-W. Yu
Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma
Int. J. Epidemiol., December 1, 2005; 34(6): 1310 - 1318.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
R. J. Hung, J. Hall, P. Brennan, and P. Boffetta
Genetic Polymorphisms in the Base Excision Repair Pathway and Cancer Risk: A HuGE Review
Am. J. Epidemiol., November 15, 2005; 162(10): 925 - 942.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J.-S. Jang, S. J. Lee, J. E. Choi, S. I. Cha, E. B. Lee, T. I. Park, C. H. Kim, W. K. Lee, S. Kam, J.-Y. Choi, et al.
Methyl-CpG Binding Domain 1 Gene Polymorphisms and Risk of Primary Lung Cancer
Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2474 - 2480.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Z. Zhang, J. Wan, X. Jin, T. Jin, H. Shen, D. Lu, and Z. Xia
Genetic Polymorphisms in XRCC1, APE1, ADPRT, XRCC2, and XRCC3 and Risk of Chronic Benzene Poisoning in a Chinese Occupational Population
Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2614 - 2619.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
W.-Y. Huang, W.-H. Chow, N. Rothman, J. Lissowska, V. Llaca, M. Yeager, W. Zatonski, and R. B. Hayes
Selected DNA repair polymorphisms and gastric cancer in Poland
Carcinogenesis, August 1, 2005; 26(8): 1354 - 1359.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Z. Hu, H. Ma, F. Chen, Q. Wei, and H. Shen
XRCC1 Polymorphisms and Cancer Risk: A Meta-analysis of 38 Case-Control Studies
Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1810 - 1818.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
Y.-T. Jeon, J. W. Kim, N.-H. Park, Y.-S. Song, S.-B. Kang, and H.-P. Lee
DNA repair gene XRCC1 Arg399Gln polymorphism is associated with increased risk of uterine leiomyoma
Hum. Reprod., June 1, 2005; 20(6): 1586 - 1589.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
R. J. Hung, P. Brennan, F. Canzian, N. Szeszenia-Dabrowska, D. Zaridze, J. Lissowska, P. Rudnai, E. Fabianova, D. Mates, L. Foretova, et al.
Large-Scale Investigation of Base Excision Repair Genetic Polymorphisms and Lung Cancer Risk in a Multicenter Study
J Natl Cancer Inst, April 20, 2005; 97(8): 567 - 576.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. Suk, S. Gurubhagavatula, S. Park, W. Zhou, L. Su, T. J. Lynch, J. C. Wain, D. Neuberg, G. Liu, and D. C. Christiani
Polymorphisms in ERCC1 and Grade 3 or 4 Toxicity in Non-Small Cell Lung Cancer Patients
Clin. Cancer Res., February 15, 2005; 11(4): 1534 - 1538.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
W. Zhou, G. Liu, S. Park, Z. Wang, J. C. Wain, T. J. Lynch, L. Su, and D. C. Christiani
Gene-Smoking Interaction Associations for the ERCC1 Polymorphisms in the Risk of Lung Cancer
Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 491 - 496.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
O. Popanda, T. Schattenberg, C. T. Phong, D. Butkiewicz, A. Risch, L. Edler, K. Kayser, H. Dienemann, V. Schulz, P. Drings, et al.
Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer
Carcinogenesis, December 1, 2004; 25(12): 2433 - 2441.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. Ito, K. Matsuo, N. Hamajima, T. Mitsudomi, T. Sugiura, T. Saito, T. Yasue, K.-M. Lee, D. Kang, K.-Y. Yoo, et al.
Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk
Carcinogenesis, August 1, 2004; 25(8): 1395 - 1401.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. C. Figueiredo, J. A. Knight, L. Briollais, I. L. Andrulis, and H. Ozcelik
Polymorphisms XRCC1-R399Q and XRCC3-T241M and the Risk of Breast Cancer at the Ontario Site of the Breast Cancer Family Registry
Cancer Epidemiol. Biomarkers Prev., April 1, 2004; 13(4): 583 - 591.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Zhu, M. R. Spitz, C. I. Amos, J. Lin, M. B. Schabath, and X. Wu
An Evolutionary Perspective on Single-Nucleotide Polymorphism Screening in Molecular Cancer Epidemiology
Cancer Res., March 15, 2004; 64(6): 2251 - 2257.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Hagmar, U. Stromberg, S. Bonassi, I.-L. Hansteen, L. E. Knudsen, C. Lindholm, and H. Norppa
Impact of Types of Lymphocyte Chromosomal Aberrations on Human Cancer Risk: Results from Nordic and Italian Cohorts
Cancer Res., March 15, 2004; 64(6): 2258 - 2263.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
X.-O. Shu, Q. Cai, Y.-T. Gao, W. Wen, F. Jin, and W. Zheng
A Population-Based Case-Control Study of the Arg399Gln Polymorphism in DNA Repair Gene XRCC1 and Risk of Breast Cancer
Cancer Epidemiol. Biomarkers Prev., December 1, 2003; 12(12): 1462 - 1467.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
N. Moullan, D. G. Cox, S. Angele, P. Romestaing, J.-P. Gerard, and J. Hall
Polymorphisms in the DNA Repair Gene XRCC1, Breast Cancer Risk, and Response to Radiotherapy
Cancer Epidemiol. Biomarkers Prev., November 1, 2003; 12(11): 1168 - 1174.
[Abstract] [Full Text]


Home page
JNCI J Natl Cancer InstHome page
M.-W. Yu, S.-Y. Yang, I-J. Pan, C.-L. Lin, C.-J. Liu, Y.-F. Liaw, S.-M. Lin, P.-J. Chen, S.-D. Lee, and C.-J. Chen
Polymorphisms in XRCC1 and Glutathione S-Transferase Genes and Hepatitis B-Related Hepatocellular Carcinoma
J Natl Cancer Inst, October 1, 2003; 95(19): 1485 - 1488.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
W.-M. Gao, M. Romkes, R. D. Day, J. M. Siegfried, J. D. Luketich, H. H. Mady, M. F. Melhem, and P. Keohavong
Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer
Carcinogenesis, October 1, 2003; 24(10): 1671 - 1676.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H.-S. Jeon, K. M. Kim, S. H. Park, S. Y. Lee, J. E. Choi, G. Y. Lee, S. Kam, R. W. Park, I.-S. Kim, C. H. Kim, et al.
Relationship between XPG codon 1104 polymorphism and risk of primary lung cancer
Carcinogenesis, October 1, 2003; 24(10): 1677 - 1681.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
L. E Eberly, J. Ockene, R. Sherwin, L. Yang, and L. Kuller
Pulmonary function as a predictor of lung cancer mortality in continuing cigarette smokers and in quitters
Int. J. Epidemiol., August 1, 2003; 32(4): 592 - 599.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
W. Zhou, G. Liu, D. P. Miller, S. W. Thurston, L. L. Xu, J. C. Wain, T. J. Lynch, L. Su, and D. C. Christiani
Polymorphisms in the DNA Repair Genes XRCC1 and ERCC2, Smoking, and Lung Cancer Risk
Cancer Epidemiol. Biomarkers Prev., April 1, 2003; 12(4): 359 - 365.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. L. Goode, C. M. Ulrich, and J. D. Potter
Polymorphisms in DNA Repair Genes and Associations with Cancer Risk
Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1513 - 1530.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
G E Goodman
Lung cancer * 1: Prevention of lung cancer
Thorax, November 1, 2002; 57(11): 994 - 999.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. Y. Park, S. H. Park, J. E. Choi, S. Y. Lee, H.-S. Jeon, S. I. Cha, C. H. Kim, J.-H. Park, S. Kam, R. W. Park, et al.
Polymorphisms of the DNA Repair Gene Xeroderma Pigmentosum Group A and Risk of Primary Lung Cancer
Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 993 - 997.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Chen, D. Tang, K. Xue, L. Xu, G. Ma, Y. Hsu, and S. S. Cho
DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population
Carcinogenesis, August 1, 2002; 23(8): 1321 - 1325.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2002 by the American Association for Cancer Research.